NASDAQ:GNMK
Delisted
GenMark Diagnostics Stock News
$24.04
+0 (+0%)
At Close: May 27, 2022
GenomeWeb Index Drops 3% for 2nd Consecutive Month
05:10pm, Tuesday, 13'th Apr 2021
Meridian Bioscience Inc. (NASDAQ:VIVO) edged out GenMark Diagnostics Inc. (NASDAQ:GNMK) as the top gainer in the March GenomeWeb Index with a 25% boost in its share price compared to GenMark's 22.5% i
INVESTIGATION ALERT: Halper Sadeh LLP Investigates LMNX, NUAN, CADE, GNMK; Shareholders are Encouraged to Contact the Firm
04:08am, Tuesday, 13'th Apr 2021
NEW YORK, April 13, 2021 /PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: Luminex Corporation (NASDAQ: LMNX) concerning po
Italian Diagnostic Developer Calls Luminex a 'Perfect Fit'
04:43pm, Monday, 12'th Apr 2021
Investors reacted favorably over the announcement that Saluggia, Italy-based DiaSorin SpA (MIL:DIA) is paying $1.8 billion to purchase Austin, Texas-based Luminex Corp. (NASDAQ:LMNX), a developer of p
GenMark Diagnostics (GNMK) Enters Overbought Territory
09:50am, Tuesday, 23'rd Mar 2021
GenMark Diagnostics (GNMK) has moved higher as of late, but there could definitely be trouble on the horizon for this company
SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of GenMark Diagnostics, Inc. - GNMK
11:05pm, Friday, 19'th Mar 2021
NEW YORK, March 19, 2021 /PRNewswire/ -- Juan Monteverde , founder and managing partner at Monteverde & Associates PC, a national securities firm rated Top 50 in the 2018 and 2019 ISS Securities C
NEW YORK and SAN DIEGO, March 16, 2021 /PRNewswire/ -- Wolf Haldenstein Adler Freeman & Herz LLP announces that it is investigating GenMark Diagnostics ("GenMark") (NASDAQ: GNMK) regarding possible br
3 Cancer Diagnostic Stocks To Watch Following Roche's GenMark Buy
11:41am, Tuesday, 16'th Mar 2021
Roche Holding AG (OTC: RHHBY) acquired GenMark Diagnostics, Inc (NASDAQ: GNMK) in a $1.8 billion deal on Monday, the same day Veracyte Inc (NASDAQ: VCYT) announced it completed the acquisition o
GenMark Diagnostics (GNMK) Soars 29.6%: Is Further Upside Left in the Stock?
06:04am, Tuesday, 16'th Mar 2021
GenMark Diagnostics (GNMK) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price
Why GenMark Stock Soared Today
09:30pm, Monday, 15'th Mar 2021
A healthcare titan is acquiring the diagnostic-test maker for a hefty premium.
SHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Investigation of GenMark Diagnostics, Inc. Buyout
06:36pm, Monday, 15'th Mar 2021
WILMINGTON, Del., March 15, 2021 (GLOBE NEWSWIRE) -- Rigrodsky Law, P.A. announces that it is investigating GenMark Diagnostics, Inc. (“GenMark”) (NASDAQ GM: GNMK) regarding possible breaches of f
GNMK Grabs Fresh Highs on Billion-Dollar Buyout Buzz
03:12pm, Monday, 15'th Mar 2021
GenMark Diagnostics Inc (NASDAQ:GNMK) stock is surging today, up 29.1% to trade at $23.88 at last check, after news of its buyout.
SHAREHOLDER ALERT: WeissLaw LLP Investigates GenMark Diagnostics, Inc.
02:40pm, Monday, 15'th Mar 2021
NEW YORK, March 15, 2021 /PRNewswire/ -- WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of GenMark Diagnostics, Inc. ("GenMar
NEW YORK and SAN DIEGO, March 15, 2021 (GLOBE NEWSWIRE) -- Wolf Haldenstein Adler Freeman & Herz LLP announces that it is investigating GenMark Diagnostics (“GenMark”) (NASDAQ: GNMK) regarding pos
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLP, a global investor rights law firm, is investigating whether the sale of GenMark Diagnostics, Inc. (NASDAQ: GNMK) to Roche is fair to GenMark shareholders.
GenMark Shares Surge After Roche Announces $1.8 Billion Deal for Molecular Test Maker
10:21am, Monday, 15'th Mar 2021
Shares of U.S.-based GenMark were shooting higher on Monday, after Swiss pharmaceutical group Roche said it will buy the California-based company.
